(1) Includes: (i) 11,157,694 shares of common stock of the Issuer (the Common Stock) held by
Live Oak Ventures, LLC (Live Oak), of which Mr. Schwab is the sole Director and has sole voting and dispositive power over the Common Stock held by Live Oak, (ii) 3,040,653 shares of Common Stock held by Charles R. Schwab &
Helen O. Schwab TTEE The Charles & Helen Schwab Living Trust U/A DTD 11/22/1985 (Trust I), of which Mr. Schwab and his spouse Helen O. Schwab are trustees, and Mr. Schwab has shared voting and dispositive power over
the Common Stock held by Trust I, and (iii) 626,826 shares of Common Stock held by Charles R. Schwab TTEE The Charles & Helen Schwab Living Trust U/A DTD 11/22/1985 (Trust II), of which Mr. Schwab is the trustee, and
Mr. Schwab has sole voting and dispositive power over the Common Stock held by Trust II.
(2) Based on 100,469,062 shares of Common Stock of the
Issuer outstanding as of October 21, 2022, excluding the issuance of an additional 3,200,000 shares from the 103,669,062 shares reported in the Registration Statement on Form S-1 filed by the Issuer
with the Securities and Exchange Commission on October 24, 2022, that were assumed to be issued pursuant to the Securities Purchase Agreement (as defined therein).
Preliminary Note This Amendment No. 2, dated October 28, 2022 (this Amendment No. 2), supplements and amends the Schedule 13G
filed on December 1, 2021 (as amended by Amendment No. 1 to Schedule 13G, dated January 5, 2022, and as further amended and supplemented to date, the Schedule 13G) relating to shares of Common Stock, $0.0001 par value per
share (the Common Stock), of Local Bounti Corporation, a Delaware corporation (the Issuer). Capitalized terms used in this Amendment No. 2 and not otherwise defined herein shall have the same meanings ascribed to them in
the Schedule 13G.
Item 4 of the Schedule 13G is hereby amended and replaced by inserting the following text.
The information relating to the beneficial ownership of Common Stock which the Reporting Persons may be deemed to beneficially own set forth in Items 5-11 on the preceding pages of this Schedule 13G is incorporated herein by reference.
Live Oak, Trust I and Trust II
collectively hold, as of October 21, 2022, 14,825,173 shares of Common Stock, which represents approximately 14.8% of the Issuers outstanding Common Stock based on 100,469,062 shares of Common Stock of the Issuer outstanding as of
October 21, 2022, excluding the issuance of an additional 3,200,000 shares from the 103,669,062 shares reported in the Registration Statement on Form S-1 filed by the Issuer with the Securities and
Exchange Commission on October 24, 2022, that were assumed to be issued pursuant to the Securities Purchase Agreement (as defined therein).
The
aggregate amount includes: (i) 11,157,694 shares of Common Stock held by Live Oak, of which Mr. Schwab is the Sole Director and has sole voting and dispositive power over Common Stock held by Live Oak, (ii) 3,040,653 shares of Common Stock held
by Trust I, of which Mr. Schwab and his spouse Helen O. Schwab are trustees, and Mr. Schwab has shared voting and dispositive power over Common Stock held by Trust I, and (iii) 626,826 shares of Common Stock held by Trust II, of which
Mr. Schwab is the trustee, and Mr. Schwab has sole voting and dispositive power over Common Stock held by Trust II.
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of
or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in
connection with a nomination under § 240.14a-11.
Page 6 of 7